BSE filing, NSE: BAYERCROP. Summary written from the filing by ALFA Finder's alert engine.
Bayer Cropscience Ltd: key numbers
- Share price
- ₹3,289.00
- Market cap
- ₹14,781 Cr
- Revenue (annual)
- ₹5,675 Cr
- Net profit (annual)
- ₹689.2 Cr
- P/E (TTM)
- 20.2×Sector 34.5×
- Promoter holding
- 71.43%+0.00% QoQ
- FII holding
- 3.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bayer Cropscience Ltd
All →Bayer Cropscience Management Change
Bayer CropScience's Cluster Commercial Lead Rajaram Mohan Babu Boppana resigned as Senior Management Personnel, effective December 31, 2026. The resignation is to pursue an external career opportunity.
Bayer Cropscience Promoter Buying (Off-Market)
Bayer CropScience Ltd reported an inter-se transfer of promoter shares via block deal between Bayer CropScience AG and Bayer AG in July 2026.
Bayer Cropscience Board Meeting Date
Bayer CropScience has intimated a Board Meeting scheduled for 3 November 2026. The agenda includes taking on record Q1 FY27 results and considering an interim dividend.
Bayer Cropscience Annual General Meeting
Bayer CropScience disclosed postal ballot results approving Mr. Ravi Kirpalani as Non-Executive Independent Director. The resolution passed with 99.99% in-favour votes on October 13, 2026.
Bayer Cropscience Other Announcement
Bayer CropScience has filed the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.
Bayer Cropscience Annual General Meeting
Bayer CropScience seeks member approval via postal ballot to appoint Mr. Ravi Kirpalani as Independent Director for five years. Voting window: September 14 to October 13, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.